David Mead
Board of Director
Genomics
Lucigen
United States of America
Biography
Dr. Mead, founder of Lucigen Corporation, is a member of the company's board of directors. Dr. Mead has twenty years of industrial experience in R&D, sales, and management at leading biotechnology companies, including BioRad, Promega, Molecular Biology Resources, Key Scientific, and Chimerx. In 1998, he founded Lucigen. Dr. Mead is a recognized expert in gene cloning and genomics. He holds eight patents, has published forty-three professional articles, and has written over fifty commercial articles in basic and applied molecular biology. He has developed more than thirty commercially successful products, including the TA cloning vectors and kits, which are the world's most widely used cloning tools—now manufactured by Life Technologies Corporation. Dr. Mead holds a Ph.D. in physiology and biophysics from the University of Illinois.
Research Interest
Molecular biology
